These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10629934)

  • 1. [Magnetic resonance angiography in multiple sclerosis].
    Pati DV; Vorobeĭchik G
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):53-7. PubMed ID: 10629934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current data on interferon therapy of multiple sclerosis in patients at developmental age].
    Smigielska-Kuzia J; Sobaniec W; Kułak W; Boćkowski L; Wołk M; Sołowiej E; Artemowicz B
    Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S45-51. PubMed ID: 15045867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of interferon beta in relapsing-remitting multiple sclerosis.
    Etheridge LJ; Beverley DW; Ferrie C; McManus E
    Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare 'palisading' enhancing pattern of multiple sclerosis.
    Huang CF; Lo CP; Tseng CY; Chen YC
    Eur Neurol; 2012; 67(3):161. PubMed ID: 22261728
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cognitive disturbances and attempts of their correction in multiple sclerosis].
    Shmidt TE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(9):54-6. PubMed ID: 16252387
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sclerosis: what have we learned from magnetic resonance imaging studies?
    Khoury SJ; Weiner HL
    Arch Intern Med; 1998 Mar; 158(6):565-73. PubMed ID: 9521220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The curious incident of disability in multiple sclerosis trials.
    Coles A
    Lancet Neurol; 2006 Nov; 5(11):899-900. PubMed ID: 17052654
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon beta treatment in relapsing-remitting multiple sclerosis. A review.
    Grigoriadis N
    Clin Neurol Neurosurg; 2002 Jul; 104(3):251-8. PubMed ID: 12127664
    [No Abstract]   [Full Text] [Related]  

  • 9. [A short history of beta-interferon therapy of multiple sclerosis].
    Stock G; Horowski R
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Sclerosis.
    Reich DS; Lucchinetti CF; Calabresi PA
    N Engl J Med; 2018 Jan; 378(2):169-180. PubMed ID: 29320652
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with beta-interferon should be started already after the first attack of MS].
    Söderström M
    Lakartidningen; 2001 Feb; 98(6):587-90, 593-4. PubMed ID: 11475246
    [No Abstract]   [Full Text] [Related]  

  • 12. Glatiramer and suspected multiple sclerosis. No proven advantage.
    Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20941852
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Time is brain' also in multiple sclerosis.
    Freedman MS
    Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of interferon beta in the treatment of multiple sclerosis].
    Seeldrayers P
    Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeing injectable ms therapies differently: they are more similar than different.
    Johnson KP; Fox RJ; Arnold DL
    Neurology; 2010 Feb; 74(8):702. PubMed ID: 20177129
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis].
    Waubant E; Sloan R; Andersson PB; Goodkin D
    Rev Neurol (Paris); 1999; 155 Suppl 2():S20-3. PubMed ID: 10367321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images.
    Barkhof F; van Waesberghe JH; Uitdehaag BM; Polman CH
    Ann Neurol; 1997 Dec; 42(6):982. PubMed ID: 9403493
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations.
    Bagnato F; Gupta S; Richert ND; Stone RD; Ohayon JM; Frank JA; McFarland HF
    Arch Neurol; 2005 Nov; 62(11):1684-8. PubMed ID: 16157739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial.
    Wolansky LJ; Haghighi MH; Sevdalis E; Cook SD; Sethi N; Liu J; Joseph G; Tulloch K; Cadavid D
    J Neuroimaging; 2005 Jul; 15(3):289-90. PubMed ID: 15951416
    [No Abstract]   [Full Text] [Related]  

  • 20. [The interferon beta therapy after the first clinical episode of demyelination in multiple sclerosis].
    Demina TL; Khachanova NV; Davydovskaia MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):15-9. PubMed ID: 16608106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.